Rajiv Gandhi Gopalsamy

Prof. Dr. Rajiv Gandhi Gopalsamy

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
RGRajiv Gandhi Gopalsamy
Rajiv Gandhi Gopalsamy
Alan Bruno Silva VasconcelosAlan Bruno Silva Vasconcelos
Alan Bruno Silva Vasconcelos
Ding-Tao WuDing-Tao Wu
Ding-Tao Wu
Hua-Bin LiHua-Bin Li
Hua-Bin Li
JPJames Antony Poovathumkal
James Antony Poovathumkal
Ren-You GanRen-You Gan
Ren-You Gan
The consumption of plant-based food is important for health promotion, especially concerning the prevention and management of chronic diseases. Flavonoids are the main bioactive compounds in citrus fruits, with multiple beneficial effects, especially antidiabetic effects. We systematically review the potential antidiabetic action and molecular mechanisms of citrus flavonoids based on in vitro and in vivo studies. A search of the PubMed, EMBASE, Scopus, and Web of Science Core Collection databases for articles published since 2010 was carried out using the keywords citrus, flavonoid, and diabetes. All articles identified were analyzed, and data were extracted using a standardized form. The search identified 38 articles, which reported that 19 citrus flavonoids, including 8-prenylnaringenin, cosmosiin, didymin, diosmin, hesperetin, hesperidin, isosiennsetin, naringenin, naringin, neohesperidin, nobiletin, poncirin, quercetin, rhoifolin, rutin, sineesytin, sudachitin, tangeretin, and xanthohumol, have antidiabetic potential. These flavonoids regulated biomarkers of glycemic control, lipid profiles, renal function, hepatic enzymes, and antioxidant enzymes, and modulated signaling pathways related to glucose uptake and insulin sensitivity that are involved in the pathogenesis of diabetes and its related complications. Citrus flavonoids, therefore, are promising antidiabetic candidates, while their antidiabetic effects remain to be verified in forthcoming human studies.

1 April 2012 in Asian Pacific Journal of Tropical Biomedicine
Verified
Journal Article
Closed access
RGRajiv Gandhi Gopalsamy
Rajiv Gandhi Gopalsamy
SPSasikumar Ponnusamy
Sasikumar Ponnusamy
To investigate the antidiabetic property of Merremia emarginata (M. emarginata) Burm. F. plant in streptozotocin induced diabetic rats. The dose dependent effects of 28 days oral treatment with methanol extract (100, 200 and 400 mg/kg) from the plant of M. emarginata on blood glucose level, body weight, insulin, total hemoglobin, glycosylated haemoglobin (HbA1C), total protein, serum urea, serum creatinine and carbohydrate metabolizing enzymes were evaluated in streptozotocin induced diabetic rats. Histology of pancreas was also studied. A significant decrease in blood glucose, serum urea and serum creatinine and significant increase in body weight, insulin and protein level were observed in diabetic rats treated with M. emarginata. Treatment with M. emarginata resulted in a significant reduction of HbA1C and an increase in total hemoglobin level. The activities of carbohydrate metabolizing enzymes such as hexokinase were significantly increased whereas glucose-6-phosphatase, fructose-1, 6-bisphosphatase were significantly decreased by the administration of M. emarginata in diabetic rats. Histology of diabetic rats treated with M. emarginata showed the pancreatic β-cells regeneration. These findings suggest that M. emarginata has potent antidiabetic activity in streptozotocin induced diabetic rats.

12 August 2022 in Critical Reviews in Food Science and Nutrition
Verified
Journal Article
Closed access
RGRajiv Gandhi Gopalsamy
Rajiv Gandhi Gopalsamy
PAPoovathumkal James Antony
Poovathumkal James Antony
Antony Ceasar StanislausAntony Ceasar Stanislaus
Antony Ceasar Stanislaus
Alan Bruno Silva VasconcelosAlan Bruno Silva Vasconcelos
Alan Bruno Silva Vasconcelos
MMMonalisa Martins Montalvão
Monalisa Martins Montalvão
Ren-You GanRen-You Gan
Ren-You Gan
Ellagitannins are vital bioactive polyphenols that are widely distributed in a variety of plant-based foods. The main metabolites of ellagitannins are urolithins, and current research suggests that urolithins provide a variety of health benefits. This review focused on the role of the gut bacteria in the conversion of ellagitannins to urolithins. Based on the results of in vitro and in vivo studies, the health benefits of urolithins, including antioxidant, anti-inflammatory, anti-cancer, anti-obesity, anti-diabetic, anti-aging, cardiovascular protective, neuroprotective, kidney protective, and muscle mass protective effects, were thoroughly outlined, with a focus on their associated molecular mechanisms. Finally, we briefly commented on urolithins’ safety. Overall, urolithins’ diverse health benefits indicate the potential utilization of ellagitannins and urolithins in the creation of functional foods and nutraceuticals to treat and prevent some chronic diseases. Graphical Abstract

9 April 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
PJPamela Chaves de Jesus
Pamela Chaves de Jesus
DSDeise Maria Rego Rodrigues Silva
Deise Maria Rego Rodrigues Silva
PMPedro Henrique Macedo Moura
Pedro Henrique Macedo Moura
RGRajiv Gandhi Gopalsamy
Rajiv Gandhi Gopalsamy
ESEloia Emanuelly Dias Silva
Eloia Emanuelly Dias Silva
LBLysandro Pinto Borges
Lysandro Pinto Borges
Background: This review examines in vitro techniques for characterizing the pharmacokinetics of medicinal plants, focusing on their role in understanding absorption, distribution, metabolism, and excretion (ADME). The diverse bioactive compounds in medicinal plants highlight the need for robust pharmacokinetic evaluations to ensure their safety and efficacy. Objectives: The objectives were to identify and analyze in vitro techniques applied to medicinal plants’ pharmacokinetics, addressing a gap in the literature. Methods: Studies were included based on predefined eligibility criteria: in vitro pharmacokinetic studies involving medicinal plants, focusing on ADME stages. Ex vivo, in vivo, and in silico studies were excluded, along with reviews. Data were collected from the PubMed, Web of Science, and Scopus databases in June 2024 using Health Sciences Descriptors (DeCS) and their MeSH synonyms. The data extracted included study location, plant species, bioactive compounds, in vitro protocols, and ADME characteristics. Results: The review included 33 studies, with most focusing on metabolism (60%), absorption (25%), or a combination of ADME aspects. Techniques like Caco-2 cells, human liver microsomes, and simulated gastric and intestinal fluids were widely used. Conclusions: The findings highlight methodological heterogeneity, including variability in extract preparation, compound concentrations, and experimental conditions, which limits the comparability and clinical applicability of results. Key limitations include the lack of standardized protocols and physiological relevance in in vitro models, underscoring the need for multidisciplinary approaches and integration with in vivo studies.

1 January 2024 in Revista da Sociedade Brasileira de Medicina Tropical
Verified
Journal Article
Open access
PDF file
MBMarina dos Santos Barreto
Marina dos Santos Barreto
RSRonaldy Santana Santos
Ronaldy Santana Santos
LSLucas Santana
Lucas Santana
RGRajiv Gandhi Gopalsamy
Rajiv Gandhi Gopalsamy
HGHARI HARAN GOVINDASAMY
HARI HARAN GOVINDASAMY
LBLysandro Pinto Borges
Lysandro Pinto Borges
Brazil is a South American country where arboviruses such as dengue, Zika, Chikungunya, and yellow fever are endemic. There are also reports of sporadic outbreaks of viruses such as the Oropouche virus (OROV), which is an Orthobunyavirus1. Although it has not received much attention, this virus was responsible for more than 7,000 documented cases in the country by July 2024, an eight-fold increase compared to the entire previous year, which saw just over 800 cases2. Recently, the first fetal death from the vertical transmission of OROV fever worldwide was documented2. The case occurred in the northeastern city of Pernambuco. The mother was 28 years old and was in her 30th week of pregnancy. A second suspected case in the same state that resulted in a miscarriage is being investigated2. Health authorities and the general population have overlooked this disease, in a similar manner to the Zika virus prior to the congenital syndrome caused by Zika raising levels of concern2. Events like this emphasize the importance of closely monitoring the public health impact of viruses like OROV. In this letter, we draw attention to OROV fever, which has been causing serious consequences in the Brazilian population, characterizing it as a public health problem. In addition to the common symptoms, such as fever, headache, nausea, vomiting, and dizziness, more intense symptoms, such as severe headache, balance dysfunction, and photophobia can occur3. In the most severe cases, neurological damage such as brain inflammation, dizziness, and lethargy can occur, as well as miscarriages and congenital damage such as microcephaly, which are possibly associated with the virus3. Recently, OROV genetic material has been identified in the umbilical cord, brain, liver, kidneys, lungs, heart, and spleen of a fetus exposed to vertical transmission3. This finding promotes a greater understanding of the importance of research on and prevention of this virus.

3 August 2025 in Sensors
Verified
Journal Article
Open access
PDF file
ERErica Milena Castro Ribeiro
Erica Milena Castro Ribeiro
Bruna De Paula DiasBruna De Paula Dias
Bruna De Paula Dias
CFCyntia Ferreira
Cyntia Ferreira
SSSamara Mayra Soares Alves dos Santos
Samara Mayra Soares Alves dos Santos
RGRajiv Gandhi Gopalsamy
Rajiv Gandhi Gopalsamy
Breno Mello SilvaBreno Mello Silva
Breno Mello Silva
Dengue, Zika, yellow fever, chikungunya, and Mayaro arboviruses represent an increasing threat to public health because of the serious infections they cause annually in many countries. Serological diagnosis of these viruses is challenging, making the development of new diagnostic strategies imperative. In this study, we investigated the effectiveness of gold nanorods (GNRs) functionalized with specific anti-dengue and anti-orthoflavivirus antibodies in detecting viral particles. GNRs were created with a length-to-width ratio of up to 5.5, a size of 71.4 ± 6.5 nm, and a light absorption peak at 927 nm, and they were treated with 4 mM polyethyleneimine. These GNRs were attached to a small amount of monoclonal antibodies that target flaviviruses, and the viral particles were detected by measuring the localized surface plasmon resonance using an UV-Vis/NIR spectrometer. The tests found Orthoflavivirus dengue and Orthoflavivirus zikaense in diluted human serum and ground-up mosquitoes, with the lowest detectable amount being 100 PFU/mL. The GNRs described in this study can be used to enhance flavivirus diagnostic tests or to develop new, faster, and more accurate diagnostic techniques. Additionally, the functionalized GNRs presented here are promising for supporting virological surveillance studies in mosquitoes. Our findings highlight a fast and highly sensitive method for detecting Orthoflavivirus in both human and mosquito samples, with a detection limit as low as 100 PFU/mL.